XML 15 R2.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2020
Dec. 31, 2019
Assets    
Cash and cash equivalents $ 305,197 $ 109,484
Accounts receivable, net of allowance for credit losses 59,674 99,513
Financing receivables, net of allowance for credit losses 126,740 128,038
Variable consideration receivable, net of allowance for credit losses 39,394 40,040
Inventories 53,021 42,989
Prepaid expenses 10,812 10,237
Film assets 7,468 17,921
Property, plant and equipment 282,854 306,849
Investment in equity securities 14,803 15,685
Other assets 23,796 25,034
Deferred income tax assets 17,737 23,905
Other intangible assets 27,019 30,347
Goodwill 39,027 39,027
Total assets 1,007,542 889,069
Liabilities    
Bank indebtedness 297,985 18,229
Accounts payable 12,011 20,414
Accrued and other liabilities 103,970 112,779
Deferred revenue 99,770 94,552
Deferred income tax liabilities 18,661  
Total liabilities 532,397 245,974
Commitments and contingencies
Non-controlling interests    
Non-controlling interests 776 5,908
Shareholders' equity    
Capital stock common shares — no par value. Authorized — unlimited number. 58,878,749 issued and 58,861,171 outstanding (December 31, 2019 — 61,362,872 issued and 61,175,852 outstanding) 405,583 423,386
Less: Treasury stock, 17,578 shares at cost (December 31, 2019 — 187,020) (271) (4,038)
Other equity 177,110 171,789
Accumulated deficit (181,604) (40,253)
Accumulated other comprehensive loss (1,984) (3,190)
Total shareholders' equity attributable to common shareholders 398,834 547,694
Non-controlling interests 75,535 89,493
Total shareholders' equity 474,369 637,187
Total liabilities and shareholders' equity $ 1,007,542 $ 889,069